Xechem’s (OTCBB: XKEM) Orphan Drug Status Approved for New Sickle Cell Drug
Recently, the EU approved "Orphan Drug Status" for Xechem International's sickle cell drug dubbed Niprisan, a phytopharmaceutical product that has…
Recently, the EU approved "Orphan Drug Status" for Xechem International's sickle cell drug dubbed Niprisan, a phytopharmaceutical product that has…
In a recent online edition of Clinical Oncology, PET scanning is introduced for the first time as a standardized method…
E-mail Power Air (OTCBB: PWAC) recently signed a Memorandum of Understanding (MOU) with Autobotics Inc regarding the recycling of zinc.…
The FCC has announced a two-year pilot program that would fund up to 85% of the costs for the…
Understanding diabetes and the role of insulin Diabetes is a common condition in which the amount of glucose (sugar) in…
With Green Fever sweeping the nation, Zap, and electric car manufacturer is looking to capitalize with its new XEBRA XERO…
Over the past year new buzzwords have entered into the realm of internet such as Web 2.0 and User Content…
Gold prices over the past week have begun to stabilize and return to their upward trend after a $50 drop…
Intelligentias' wholly-owned subsidiary is currently bolstering its sales marketing force in the likelihood that the ‘Safety Bill’ will pass through…
The recent seizure of 15 British Royal Sailors and Marines has once again placed a flashpoint in the Middle East. …